Table 2.
Putative Stem Cell (Species) | Location/s in the Lung |
Serial Xenografting Performed |
Association with Prognosis when Present in Tumors |
References |
---|---|---|---|---|
Bronchoalveolar stem cell (BASC) IF: CC10+SPC+FACS:Sca1 +CD45-Pecam- (mouse) |
Bronchoalveolar duct junction |
Yes | Not known | Kim et al (2005)100 |
Reparative cell IF: K14+K5 +FACS: N/A (human) |
Submucosal gland duct, submucosal glands, repairing airway epithelium, preneoplastic lesions |
No | p=0.003 | Ooi et al (2010)116 |
CD133+IF and FACS (human) | Not known | Yes | −CD133+Not significant for prognosis |
Eramo et al (2008)108 |
−CD133+ABCG2+predicts recurrence in stage I NSCLC p=0.015 |
Bertolini et al (2009)110 |
|||
−Associated with resistance to chemotherapy |
Salnikov et al (2010)109 Li et al (2010)111 |
|||
ALDH+ (human) | Not known | Yes | p=0.009 | Jiang et al (2009)107 |
−Associated with resistance to chemotherapy |
ALDH, aldehyde dehydrogenase; K14, keratin 14; K5, keratin 5; CC10, Clara cell secretory protein; SPC, surfactant protein C.
EVOLVING CONCEPTS IN LUNG CARCINOGENESIS/GOMPERTS ET AL 37
Downloaded by: UT Southwestern Medical Center. Copyrighted material.